In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merckle GmbH

Division of Teva Pharmaceutical Industries Ltd.

Latest From Merckle GmbH

Specialty Pharma: Tapping Japan

Economic recovery, pharmaceutical consolidation, and a burgeoning private equity sector have encouraged a new cluster of Japan-focused specialty pharmas
BioPharmaceutical North America

Cephalon: Can Spec Pharma do R&D?

Cephalon's 2005 dealmaking flurry illustrates the growing influence of in-house R&D on a firm whose success to date has come from in-licensing. Its challenge will be selling investors pipeline potential, as well as earnings growth.
BioPharmaceutical Strategy

Novartis/Hexal: Generic Consolidation, and More

Buying Hexal shows Novartis' commitment to generics. The Swiss group also hopes the move will bring more credibility, and better deals, across all of its businesses.
BioPharmaceutical Strategy

The Winners Post-Vioxx: Merck's Product-Focused Biotechs

Vioxx's withdrawal late in September just made partnering success even more critical to Merck & Co. With a $2.55 billion gap in revenues from Vioxx and having lost two Phase III development products late in 2003, the company now leans more heavily still on external R&D success. That's good news for Merck's partners--particularly those with products.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Teva Pharmaceutical Industries Ltd.
  • Senior Management
  • Gerhard Strugala, Dir., Research & Licensing
    Gunter Vogel, Dir., Mktg.
  • Contact Info
  • Merckle GmbH
    Phone: (49) 734 44140
    Im Gehrn 3
    Blaubeuren, W-7902